Fletikumab Biosimilar – Anti-IL20 mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameFletikumab Biosimilar - Anti-IL20 mAb - Research Grade
SourceCAS 1357158-22-5
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsFletikumab,15D2,NN-8226,NNC-0109-0012,IL20 ,anti-IL20
ReferencePX-TA1336
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Fletikumab Biosimilar - Anti-IL20 mAb - Research Grade

General information on Anti-IL20 [Homo sapiens] (Fletikumab) Monoclonal Antibody

Fletikumab is investigated for the treatment of Rheumatoid Arthritis.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Fletikumab Biosimilar – Anti-IL20 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human IL20 recombinant protein
Antigen

Human IL20 recombinant protein

PX-P6066 385€
Stable Isotope Labelled Fletikumab Biosimilar – Anti-IL20  mAb – Research Grade
SIL

Stable Isotope Labelled Fletikumab Biosimilar – Anti-IL20 mAb – Research Grade

PX-TA1336-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products